HCA Midwest Health Kansas City — Kansas City, Missouri

HCA Midwest Health Kansas City is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

HCA Midwest Health Kansas City has participated in 3 clinical trials.

Therapeutic areas: Non Hodgkin Lymphoma, Endometrial Cancer, KRAS p, G12c Mutated /Advanced Metastatic NSCLC.

Sponsors: Rhizen Pharmaceuticals SA, Karyopharm Therapeutics Inc, Amgen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Health Kansas City?

HCA Midwest Health Kansas City has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Health Kansas City conducted?

HCA Midwest Health Kansas City has 3 clinical trials on record. Their work covers Non Hodgkin Lymphoma, Endometrial Cancer, KRAS p, G12c Mutated /Advanced Metastatic NSCLC.

Is HCA Midwest Health Kansas City accredited by Crixeo Clinical Trials?

HCA Midwest Health Kansas City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Health Kansas City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.